| Literature DB >> 25538249 |
M Jack Borrok1, Yanli Wu1, Nurten Beyaz1, Xiang-Qing Yu2, Vaheh Oganesyan1, William F Dall'Acqua3, Ping Tsui4.
Abstract
The Fc domain of IgG has been the target of multiple mutational studies aimed at altering the pH-dependent IgG/FcRn interaction to modulate IgG pharmacokinetics. These studies have yielded antibody variants with disparate pharmacokinetic characteristics, ranging from extended in vivo half-life to those exhibiting extremely rapid clearance. To better understand pH-dependent binding parameters that govern these outcomes and limit FcRn-mediated half-life extension, we generated a panel of novel Fc variants with high affinity binding at acidic pH that vary in pH 7.4 affinities and assessed pharmacokinetic outcomes. Pharmacokinetic studies in human FcRn transgenic mice and cynomolgus monkeys showed that multiple variants with increased FcRn affinities at acidic pH exhibited extended serum half-lives relative to the parental IgG. Importantly, the results reveal an underappreciated affinity threshold of neutral pH binding that determines IgG recycling efficiency. Variants with pH 7.4 FcRn affinities below this threshold recycle efficiently and can exhibit increased serum persistence. Increasing neutral pH FcRn affinity beyond this threshold reduced serum persistence by offsetting the benefits of increased pH 6.0 binding. Ultra-high affinity binding to FcRn at both acidic and neutral pH leads to rapid serum clearance.Entities:
Keywords: Antibody Engineering; Fc Receptor; FcRn; Monoclonal Antibody; Phage Display; Pharmacokinetics
Mesh:
Substances:
Year: 2014 PMID: 25538249 PMCID: PMC4326836 DOI: 10.1074/jbc.M114.603712
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157